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The field of structural biology is increasingly focusing on studying proteins in situ, 
i.e. in their greater biological context. Crosslinking mass spectrometry is contributing 
to this effort, typically through the use of MS-cleavable crosslinkers. Here, we apply the 
popular non-cleavable crosslinker disuccinimidyl suberate (DSS) to human 
mitochondria and identify 5,518 distance restraints between protein residues. Each 
distance restraint on proteins or their interactions provides structural information 
within mitochondria. Comparing these restraints PDB deposited structures and 
comparative models detects novel protein conformations. Our data suggest amongst 
others substrates and protein flexibility of mitochondrial heat shock proteins. Through 
this study we bring forward two central points for the move of crosslinking mass 
spectrometry towards large-scale in situ structural biology: clustered better than error-
rich individual conflicts of crosslink data with other structural data reveals in situ 
protein conformation states and non-cleavable crosslinkers are compatible with 
proteome-wide studies. This opens the field for in situ photo-crosslinking or other 
functionalised crosslinkers which were excluded so far from large-scale studies. 
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Mitochondria are complex organelles that fulfil a wide set of essential cellular functions 
including energy metabolism in all eukaryotic cells 1. Damaged and dysfunctional mitochondria 
are implicated in several metabolic, cardiovascular and neurological disorders, and also 
cancer 1–5. To fully understand the molecular basis of mitochondrial physiology and its role in 
disease, it is essential to identify all the relevant components and to reveal their structure and 
interactions. Human mitochondria have 1,157 proteins currently annotated in MitoCarta 2.0 6, 
for fewer than 300 of these we found structures deposited in the PDB, often only covering 
fragments of the proteins. Commonly used structural biology techniques usually require 
purification of proteins, which may compromise their structure, solubility or stability 7–9. Ideally 
structure elucidation is done in the protein’s native context. In situ techniques such as in-cell 
NMR 10–12, fluorescence microscopy 13,14 or cryo-electron tomography 15,16 are developing 
quickly but still only target individual proteins or protein complexes of interest. 
Crosslinking mass spectrometry (CLMS) is a technique that can provide in situ middle-
resolution structural information for individual multi-protein complexes and can be scaled up 
to more complex samples such as entire organelles 17 or bacterial cells 18–20. Distance 
restraints are generated by identifying which residues were crosslinked in a protein or between 
two interacting proteins and considering the length of the most extended conformation of the 
crosslinking reagent. Until recently, complex biological samples could only be tackled by the 
use of crosslinkers that cleave in the mass spectrometer 19–23 or by the use of isotope-labelled 
crosslinker which create a special isotope pattern to aide identifying crosslinked peptides 24,25. 
Two recent studies investigated murine mitochondria using MS-cleavable crosslinkers and 
reported 1,876 22 and 2,779 23 crosslinked residue pairs (excluding ambiguous crosslinks, 
where one of the crosslinked peptides could have come from a number of proteins), 
respectively. These studies focused on the discovery of protein-protein interactions and 
partially on in situ protein structure analysis while possible gains of systematic analysis of 
protein flexibility have been less explored.  
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Here, we use in situ CLMS to analyse protein structures in human mitochondria. Our 
crosslink-derived distance restraints combined with high-throughput comparative protein 
modelling reveal protein interactions and protein flexibility in their native environment. Due to 
the experimental error associated with single crosslinks we focus our analysis on systematic 
conflicts between structural models and our in situ distance restraints. This critically depends 
on data density, for which we designed a workflow around a standard crosslinker that 
combines sequential protein digestion 26, orthogonal peptide fractionation methods, and a 
decision-tree-based MS acquisition strategy 27. Importantly, our workflow demonstrates how 
analysis of complex systems with non-MS-cleavable crosslinkers, including oxidative 
crosslinkers 28, photoactivatable amino acids 29,30 and photoactivatable crosslinkers 31,32, is 
now possible and which types of insights that such data add to our understanding of protein 
structures in situ.  
 
Experimental Section 
Reagents. Disuccinimidyl suberate (DSS) and Trypsin were purchased from Thermo Scientific 
Pierce (Rockford, IL). The proteases GluC, Chymotrypsin and AspN were purchased from 
Promega (Madison, WI). 
  Cell culture and preparation of human mitochondria. K-562 cells (DSMZ, Cat# ACC-
10) were grown at 37 °C under a humidified atmosphere containing 5% CO2 in RPMI 1640 
containing 10% fetal bovine serum. 400 million K-562 cells were collected by centrifugation 
and washed twice with phosphate buffered saline (PBS). Cell lysis and mitochondria 
preparation was performed using a protocol adapted from Clayton and Shadel 33. Briefly, cell 
lysis was carried out in 5.5 mL ice-cold RSB hypotonic buffer (10 mM HEPES pH 7.5, 10 mM 
NaCl, 1.5 mM MgCl2) using dounce homogenization. 4 mL ice-cold 2.5 x MS homogenization 
buffer (12.5 mM HEPES pH 7.5, 525 mM mannitol, 175 mM sucrose, 2.5 mM EDTA) was 
added to obtain an isotonic solution. To clarify the cell lysate, it was centrifuged three times at 
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1,300 x g (5 min, 4 °C). The mitochondria were pelleted by centrifugation at 12,360 x g (15 min, 
4 °C) and washed once with 5 mL ice-cold 1x MS homogenization buffer. The isolated 
mitochondria were resuspended in 20 mM sodium phosphate pH 8.0, 150 mM NaCl. The 
protein concentration was estimated via Bradford Assay (BioRad). Aliquots of isolated 
mitochondria were frozen in liquid nitrogen and stored at -80 °C. 
  Crosslinking reaction, tryptic in-solution-digestion and peptide purification. Isolated 
mitochondria were washed twice in ice-cold PBS and pelleted at 16,000 x g (5 min at 4 °C). 
2 mg proteins were chemically crosslinked using 0.225 mM DSS in DMSO which equals a 
protein-to-crosslinker ratio of 12:1 at 1 mg/mL protein concentration in 2x1 mL in 4x 500 µL 
crosslinking reaction. Note that a DSS concentration optimization experiment was performed 
beforehand to find the proximate saturation point of DSS-to-mitochondria ratio by SDS-PAGE 
and CLMS (further details see supporting material, Fig. S1). After 40 min incubation at 25 °C 
and gentle agitation, crosslinking reaction was quenched by adding ammonium bicarbonate 
(ABC) to a final concentration of 50 mM (15 min at 25 °C). Samples were evaporated 
completely to minimize the volume for tryptic digestion. 2 mg of crosslinked mitochondria were 
denatured using 6 M urea, 2 M thiourea in 50 mM ABC and reduced with 5 mM dithiothreitol 
(DTT) 20 min at 50 °C. To alkylate reduced disulfide bonds, 15 mM iodoacetamide (IAA) was 
added and incubated 30 min at 25 °C in the dark. After diluting with 50 mM ABC to a final 
concentration of 2 M urea/thiourea, trypsin was added at an enzyme-to-substrate ratio of 1:50 
and incubated overnight at 37 °C, with gentle agitation. The in-solution-digestion was stopped 
by adding 10% (v/v) trifluoroacetic acid (TFA) until pH ≤ 2. Peptide desalting and purification 
was performed using EmporeTM Solid Phase Extraction Cartridges C18-SD according to 
manufacturer’s protocol. Afterwards, the sample was divided in four portions of 500 µg tryptic 
peptides each.  
Fractionation of Peptides by Strong Cation Exchange Chromatography. The tryptic 
peptides were fractionated using strong cation exchange chromatography (SCX, Fig. 1A) as 
previously described 34. In our workflow, four aliquots of each 500 µg peptides were dried in a 
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vacuum concentrator and resuspended in 105 µL SCX buffer A (20 mM monopotassium 
phosphate pH 2.7, 30% (v/v) acetonitrile (ACN)). 100 µL peptide samples were loaded onto a 
PolyLC Polysulfoethyl ATM 100 x 2.1 mm, 3 µm, 300 Å column operated by Shimadzu HPLC 
system. Peptides were fractionated by increasing the salt concentration (SCX buffer B: 20 mM 
monopotassium phosphate pH 2.7, 30% (v/v) ACN, 500 mM KCl) with following settings: 
constant flow rate of 0.2 mL/min, 0% B (0‑5 min), 0-5% B (5‑10 min), 5-20% B (10‑14 min), 
20-60% B (14‑18 min), 60-70% B (18‑21 min), 70-100% B (21‑25 min). Two minute fractions 
were collected and seven selected fractions were partially pooled and evaporated completely, 
resulting in a total of 5 SCX fractions (14+15, 16, 17, 18 and 19+20 like shown in Fig. S2). 
Sequential Digestion (SD) and Size Exclusion Chromatography (SEC). Three of the 
four 500 µg peptide samples were sequentially digested using a second protease after SCX 
fractionation (Fig. 1A) as previously described in Mendes et al. 26. The protease amounts 
added were adjusted to the peptide content of each SCX fraction. The selected SCX fractions 
were resuspended in 50 µL 50 mM ABC and digested using either GluC (1:50 protease-to-
substrate ratio), Chymotrypsin (1:50) or AspN (1:100). After overnight incubation 
(Chymotrypsin at 25 °C, GluC and AspN at 37 °C), the protease digestion was stopped using 
10% (v/v) TFA. Evaporated sequential digested or tryptic digested samples were resuspended 
in 40 µL SEC buffer (30% (v/v) ACN, 0.1% (v/v) TFA) and fractionated using SEC as previously 
described 35. In our workflow, peptides were fractionated using a Superdex Peptide 3.2/300 
column (GE Healthcare) operated by Shimadzu HPLC system at a flow rate of 0.05 mL/min in 
a 60 min isocratic gradient with SEC buffer. Two minute fractions were collected and, 
depending on the sample amount, two up to six early eluting SEC fractions were selected 
(Fig. S2). Due to the expectation that crosslinked peptides are overall larger than linear 
peptides, we selected only early SEC fractions for MS acquisitions. This entire workflow 
resulted in 88 different SCX-SD-SEC fractions which were evaporated completely and 
resuspended in 4 µL 0.1% (v/v) FA. 
7 
 LC-MS/MS acquisition. A total of 110 MS runs were analysed as previously 
described 27 using an UltiMate 3000 Nano LC system coupled to an Orbitrap Fusion Lumos 
Tribrid mass spectrometer (Thermo Fisher Scientific, San Jose, USA). SCX-SD-SEC fractions 
with large sample amounts were injected as technical duplicates. Briefly, mobile phase A 
contained 0.1% (v/v) FA in water and mobile phase B 80% (v/v) ACN and 0.1% (v/v) FA in 
water. Fractionated peptides were injected onto a 500 mm C-18 EasySpray column (75 µm 
ID, 2 µm particles, 100 Å pore size) and separated using a constant flow rate of 250 nL/min. 
Depending on the sample amount per fraction, a linear gradient from 4‑40% mobile phase B 
was employed for either 60 min or 139 min for peptide elution. MS1 spectra were acquired at 
120,000 resolution in the orbitrap with AGC target of 2 x 105 ions and a maximum injection 
time of 50 ms. For fragmentation precursor ions with charge states 3-8 and an intensity higher 
than 5 x 104 were isolated using an isolation window of 1.4 m/z (AGC target 1-5 x 104, 60 ms 
max. injection time). Depending on the charge state and the m/z ratio, precursor ions were 
fragmented with energies based on the optimized data-dependent decision tree using 
HCD/EThcD fragmentation 27. MS2 spectra were recorded at 30,000 resolution in the orbitrap. 
Identification and validation of crosslinked peptides. MS raw data were converted to 
mgf format using msconvert, including a peak filter for the 20 most abundant peaks per 
100 m/z window for further data analysis (Fig. 1A). Resulting peak files were analysed by Xi 
(version 1.6.731 26, using the following settings: MS tolerance 6 ppm, MS2 tolerance 20 ppm, 
potential missing monoisotopic peaks 3 36, enzyme dependent on respective single or 
sequential digestion (trypsin or trypsin + AspN, trypsin + GluC, trypsin + chymotrypsin), fixed 
modification carbamidomethylation of cysteine, variable modification oxidation on methionine, 
losses –CH3SOH, –H2O and –NH3, crosslinker BS3 (mass equivalent in crosslinked state, 
mass modification 138.06807 Da) with variable crosslinker modifications (“BS3-NH2” 
155.0946 Da, “BS3-OH” 156.0786 Da). The DSS crosslinker was assumed to react primarily 
with lysine residues, but also with serine, threonine, tyrosine or the protein N-terminus. 
Besides precursor-ions were the corresponding b- and y-fragment ions searched for HCD 
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fragmentation; for EThcD b-, c-, y- and z-fragment ions were considered. Obtained peptide 
spectra were matched to a database constructed either from the MitoCarta 2.0 database of 
annotated human mitochondrial proteins (1,157 protein IDs 6, Tab. S1B) or including the most 
abundant proteins in all crosslinked and SCX-SD-SEC fractionated samples (1,118 protein 
IDs Tab. S1B, see expanded material of linear MaxQuant Search in Tab. S1A). To filter for 
high confidence data a false discovery rate (FDR) of 5% on link level was applied on the 
identified crosslinked peptides using xiFDR 37. Note that unlike other FDR calculations, our 
xiFDR groups identified peptides into putative self- or PPI-links to avoid an accumulation of 
false positives for self-links. Crosslinks within one protein were calculated using following 
settings: pre-filter crosslinks only, 5 amino acids as minimum peptide length. Crosslinks 
between two different proteins were analysed with the following parameters: pre-filter 
crosslinks only, delta score 0.5, minimum number of fragments per peptide 5, with 8 amino 
acids as minimum peptide length. 
Mitochondrial protein localisation. The known localizations of 915 mitochondrial 
proteins were assigned according to MitoCarta and UniProt subcellular location information 
(see Tab. S1B). Remaining mitochondrial proteins from MitoCarta were annotated as “other 
mitochondrial localisation”.  
Crosslink assessment using models from PDB. We investigated crosslinks by mapping 
the residue pairs to all available PDB structures. For crosslinks within the same protein, we 
mapped the crosslinks on available monomeric structures and, where applicable, also on 
homomultimeric structures. For some proteins there are several PDB structures or 
comparative models available, in which we mapped our self-links to the shortest distance in 
any given structure. Then, for each crosslinked residue pair we calculated the Euclidean 
distance between the Cα atoms within the PDB structures. We consider a crosslink in 
agreement with the PDB model if the Cα-Cα distance is smaller or equal to 30 Å 38. If not, we 
consider a crosslink to be a long-distance link. We use the SIFTS database 39 to map the 
canonical UniProt sequences in our search database to available PDB structures. Note that 
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for a unique, canonical UniProt 40 sequence, there might be multiple PDB structures available. 
In this case, we calculate the distances for all PDB structures and take the shortest, including 
homooligomeric interfaces. 
Protein structure modelling. We performed comparative modelling on 363 proteins with 
unknown structure. The modelling procedure consists of four steps: First, we generate a 
sequence profile of the target sequence by searching for homologous sequences with 
HHblits 3.0.0 41. Second, used the profiles to search the PDB70 database from February 2017 
using HHSearch 42. We accept a template for a given protein sequence, if the negative 
logarithm of the HHSearch had a p-value ≥ 6.5 43, which corresponds to the threshold for a 
remote structure. If all templates for a protein do not satisfy this criterion, we do not model the 
structure because no reliable templates can be identified by HHsearch. Third, we used 
MODELER 9.12 44 to generate fifty comparative models for each protein. Fourth, we used 
PROSA 45 to select the top scoring comparative model for each protein. We used normal mode 
analysis (NMA) to model dynamics by using the web-based elNémo software 46,47 and 
ProDy 48. During modelling, we use the template quality as a proxy to measure the quality of 
the resulting comparative models. HHsearch found template hits for 654 proteins for which we 
also identified crosslinks, 363 of which had no experimental structure in humans. Swiss-
model 49 was used for the modelling of the ATP synthase as well as for the complex III of the 
OXPHOS complex. 
Structure visualisation and protein docking. Structures were visualized with UCSF 
Chimera 50 and PyMol Molecular Graphics System, Version 2.0 Schrödinger, LLC. During 
highlighting crosslinked amino acids in the Hsp60 protein complex (Fig. 3B/C), the crosslinked 
K551 was not present in the PDB structure, therefore the neighbouring amino acids were 
modelled using MODELLER 44. For protein docking, we used the HADDOCK web service with 
default parameters 51,52. Crosslinks between domains were set as unambiguous distance 
restraints with an upper limit of 30 Å in docking calculations. Centre of mass restraints was 
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enabled. To account for the peptide sequence between the domains, we imposed an upper 
limit of 35 Å. 
 
Results and Discussion 
Crosslinking of human mitochondria using a non-cleavable crosslinker 
Human mitochondria (K-562 cells) were crosslinked using the homobifunctional and 
membrane permeable reagent disuccinimidyl suberate (DSS) (Fig. 1A). Following tryptic 
digestion, peptides were fractionated using strong cation-exchange chromatography (SCX) 
into five fractions with an enrichment of crosslinked peptides in higher salt fractions 24,53 
(Fig. S2). The individual fractions were then subjected to our novel sequential digestion 
protocol (see Experimental Section for details, Fig. 1A) 26. The second digestion step 
preferentially shortens large and thus difficult-to-observe peptides, due to the proteases 
having reduced cleavage efficiency for shorter peptides 26,54. All fractions were then subjected 
to size-exclusion chromatography (SEC) to further enrich for crosslinked peptides 
(Fig. S2B) 26,35,54. Only early SEC-fractions, those enriched for crosslinked peptides, were 
analysed by LC-MS/MS using a data-dependent decision tree of optimised fragmentation 
energies for crosslinked peptides 27. The database of protein sequences for crosslink search 
was generated by combining the most abundant 1,000 proteins (Tab. S1A) in our 
mitochondrial preparations with all proteins listed in MitoCarta (total proteins 1,660, Tab. S1B). 
In total, we identified 12,664 unique crosslinked peptide pairs (excluding ambiguous 
crosslinks, Tab. S2A) which correspond to 5,518 unique residue pairs in 792 proteins (5% link-
level FDR 37). The majority of the proteins and protein-protein contacts were identified by 
multiple residue pairs (Fig. 1B/C). Of these, 5,366 are putative self-links (Molecular 
Interactions Controlled Vocabulary ID: 0898, Tab. S2B, from here referred to as “self-links” for 
simplicity). Self-links fall either within one or between two copies of the same protein. Some 
proteins such as malate dehydrogenase (MDHM), mitochondrial stress 70 protein (GRP75) 
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and 60 kDa heat shock protein (Hsp60) were covered by more than 100 residue pairs (Fig. 1B), 
which suggests the presence of abundant structural information in our data at least for some 
proteins. Overall 4,034 self-links mapped to 513 (44% of 1,157) proteins of MitoCarta 
(Fig. 1D). The majority of identified links were identified on mitochondrial matrix proteins 
consistent with DSS crosslinker passing through both mitochondrial membranes (54%, 
Fig. 1D), although we cannot exclude the presence of fractured or lysed mitochondria. 
Furthermore, we identified 1,335 crosslinks in 255 proteins that are not included in MitoCarta. 
According to UniProt, some of these proteins are localised in mitochondria. However, the 
majority of these proteins are assigned to cytosolic cellular functions or belong to the 
endoplasmic reticulum which is connected to the mitochondria and likely constitute 
background of our purification. Nevertheless, our human mitochondria preparation was highly 
enriched. As one would expect, we identified crosslinks exclusively in the more abundant 
proteins (Fig. S3) while crosslinks between proteins displayed an even higher bias towards 
highly abundant proteins. This underpins the general challenge of detecting crosslinked 
peptides. This also supports our decoy-based FDR-approach for error assessment as random 
false identifications should not show an abundance bias. 
Despite our departure from non-MS-cleavable crosslinkers, we identified more 
crosslinks than previous studies using MS-cleavable crosslinkers (Fig. S5A). There is a set of 
possible contributing factors: We countered some of the disadvantages of standard 
crosslinkers by optimised data acquisition 27 and breakdown of the combinatorial search 
space 55. In contrast to others, our study employed sequential digestions 26 which boost our 
number of identifications up to 65% by shortening the average peptide length from 33 amino 
acids for crosslinked tryptic peptides to 22-24 amino acids for crosslinked sequentially 
digested peptides (Fig. S4A/B). However, tryptic data contributed 4,481 peptide pairs 
(Fig. S4C) which still compares favourably to previous analyses of mitochondria which yielded 
in total 2,427 22 and 2,779 peptide pairs 23. Note that although NHS-esters preferably crosslink 
primary amines such as found in lysine side chains, there is a known side reaction with the 
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hydroxyl groups of S/T/Y residues 56,57. These crosslinks were not considered in the previously 
published studies, but they contributed to 3,066 crosslinked peptide pairs (33%) in our full 
dataset (Fig. S4D/E). Moreover, monoisotopic peak correction during database search 36 
make up to 40% peptide spectrum matches in our full dataset (Fig. S4F). However, a direct 
comparison of all three studies is hampered by many parameters that differ between them, 
including sample origin, digestion method, fractionation methods, fractionation depths, 
acquisition method and time, data analysis software and finally FDR estimation with various 
filter settings and grouping of PPI- and self-links 37. 
 
 
Fig. 1: Workflow, data density and quality of crosslinking mass spectrometry analysis in human 
mitochondria. (A) Overview of crosslinking pipeline in human mitochondria. Sample preparation (upper panel): 
Isolated mitochondria were crosslinked using the membrane-permeable crosslinker disuccinimidyl suberate (DSS). 
Proteins were digested with trypsin and the resulting peptides were fractionated by strong cationic exchange 
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chromatography (SCX). Each fraction was then subjected to size exclusion chromatography (SEC) which enriches 
for crosslinked peptides in early fractions. SEC was conducted either directly or following an additional digestion 
step by either GluC, AspN or chymotrypsin, which preferentially cleaves large peptides to enhance their detection 
during the subsequent mass spectrometric analysis 26,54. Data analysis (lower panel): The acquired MS/MS spectra 
were searched against a sequence database using Xi 26. Crosslinks were filtered to 5% false discovery rate using 
xiFDR 37 and used to analyse protein-protein interactions in xiNET 58 and for protein structure modelling. (B) The 
majority of proteins detected with putative self-links are seen with multiple crosslinks. Stress 70 protein (GRP75), 
malate dehydrogenase (MDHM) and 60 kDa heat shock protein (Hsp60) have more than 100 self-links. (C) The 
majority of protein pairs identified with crosslinks are based on a single PPI-link. Protein-protein interactions 
between ATP synthase subunits (ATPA, ATPB, ATPO) and prohibitin – prohibitin 2 (PHB-PHB2) are characterised 
by up to 20 unique PPI-links. (D) Localisation of identified residue pairs of self-links within the human mitochondrion. 
 
CLMS data reveals conformations adopted by proteins in situ 
We compared our self-links against experimental structures deposited in the PDB or, where 
none were available, to comparative models based on structures from other species (see 
Experimental Section). 2,215 (41.3% of 5,366) crosslinks mapped on 343 proteins with human 
PDB structures (green subset in Fig. S6A/C, Tab. S4A) and furthermore 1,290 crosslinks on 
256 proteins with comparative models (blue subset in Fig. S6A/D, Tab. S5A). Focussing on 
monomeric PDB structures, 219 crosslinks (9.9%, Fig. S6B) surpassed 30 Å C⍺-C⍺ distance, 
an empiric upper boundary for DSS crosslinking that is also supported by molecular dynamics 
simulations 38. By considering known homomultimerisation, this reduced to 129 long-distance 
self-links in PDB entries (5.8%, Fig. S6B/C). Thus, considering homomultimeric states 
resolved conflicts for 90 links. At least 66 of the remaining 129 long-distance self-links in 
47 PDB entries will be rationalised below in the context of conformation changes, further 
reducing the apparent conflict between our self-links and PDB data to below 3% (Fig. S6B, 
Tab. S4B). Additionally, we identified 68 crosslinks with zero sequence separation (Tab. S2B) 
which cannot stem from the same protein molecule. These self-links may indicate 
homomultimerisation, but may also be artefacts due to non-covalent association of the 
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peptides during mass spectrometric measurement 59 and thus were excluded from our 
structural analyses. 
We investigated clusters of long-distance links to see whether they may reveal novel 
structural states in situ. As mentioned, homomultimerisation resolved long-distance links. 
Some of these were clustered, for example in the case of the beta subunit of the 
methylcrotonoyl-CoA carboxylase as part of the MCCC complex. 15 self-links match the 
monomeric structure while three were in conflict with it (Fig. S7A left panel). Using the 
oligomeric orthologous from Pseudomonas aeruginosa (PDB 3U9S) as template for modelling 
harmonised these conflicts (Fig. S7A right structure), consistent with a homooligomeric 
structure also of the human MCCC2 complex.  
Furthermore, we found several cases of clustered conflicts which indicate protein 
flexibility in situ. The mitochondrial elongation factor Tu had six long-distance links (out of 57 
self-links) which connect from different parts of the protein to the beta sheet domain (shown 
at the bottom in Fig. S7B, left panel). A normal mode analysis of our comparative model 
suggests a domain movement towards the core structure (indicated with an arrow in Fig. S7B, 
right panel) that reduces all long-distance links. We find an analogous protein flexibility in the 
mitochondrial OXPHOS supercomplex (complex I1III2IV1) which is critical for ATP production 
in mitochondria. Overall, we see an excellent agreement with previous structural data (PDB 
5XTH, Fig. S7C), but 20 out of 196 distance restraints (10.2%) exceed 30 Å Cα-Cα distance. 
Seven long-distance links clustered in complex I, involving the proteins NADH dehydrogenase 
[ubiquinone] 1 alpha subcomplex subunit 7 (NDUA7), NADH dehydrogenase [ubiquinone] 
iron-sulfur protein 2 and 3 (NDUS2, NDUS3). Especially NDUA7 consists of extensive 
unstructured protein segments (Fig. S7C) which contributes to protein flexibility in this region 
of complex I. Extending in situ structural analysis to another OXPHOS complex, we visualised 
distance restraints also in ATP synthase (complex V). In the absence of a human structure, 
we mapped human protein sequences into the bovine structure, which is available in different 
states of the ATP production cycle 60. Resulting models and crosslinks were in excellent 
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agreement (187 out of 199 fall below 30 Å, Fig. S7D). Crosslinks fell within each of the major 
extra membrane domains of the ATP synthase (rotor, peripheral stator and α3β3 core subunit). 
The 12 distance restraints that exceed our 30 Å cut-off did not cluster and were thus not used 
to propose conformational changes. 
The two structurally solved domains of Hsp70 (PDB 4KBO, 3N8E) covered 60 of the 
identified 134 self-links and could be arranged using the full-length model of the E. coli 
orthologue (PDB 2KHO, grey structure in Fig. 2A upper panel). However, crosslink data 
disagreed with the resulting interface of both domains (highlighted in orange, Fig. 2A) for which 
also in E. coli some flexibility has been reported 61. Docking the domains using crosslink 
restraints in HADDOCK 51,52 resolved many conflicting crosslinks (Fig. 2A lower panel). This 
previously undescribed arrangement proposed by CLMS might occur during protein 
regulation. In fact, crosslinking also captured the regulatory mitochondrial GrpE protein 
homolog 1 62 in the substrate binding domain of Hsp70 (Tab. S6). Our CLMS data therefore 
suggest that negative regulation by GrpE may require a dramatic dynamic process of both 
Hsp70 domains (as indicated by an arrow in Fig. 2A lower panel). 
The most striking conflict with established structures was observed for the 60 kDa heat 
shock protein (Hsp60). We identified 291 self-links, including 61 long-distance crosslinks, 
almost all of which indicate a compression of the heptameric Hsp60 ring (PDB 4PJ1, Fig. 2B). 
The orthologous chaperonin GroEL/GroES system in E. coli has flexible apical domains that 
can be attributed to the ability of chaperonin to bind different substrates or to the involvement 
of the apical domains in substrate unfolding processes 63–65. In comparison, the human 
chaperonin structure shows more intense asymmetric movements within the Hsp60 ring 
subunits which were previously suggested not to be concerted 66. In contrast, our in situ CLMS 
data show clustered long-distance restraints with anchor points on the opposite side of the 
heptameric Hsp60 ring structure (Fig. 2B). This indicates a compression-like movement of 
Hsp60 in situ (indicated with an arrow in Fig. 2B). Therefore we mapped also our distance 
restraints to the GroEL structure (PDB 4AAQ) which has a narrow structure (Fig. 2C). This 
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solved nearly half of the conflicting distance restraints. The remaining conflicts suggest an 
even higher degree of protein flexibility. Consequently, substrate binding and/or unfolding 
might require directed movements within the human chaperonin ring similar to but possibly 
exceeding those described for the ATP-dependent E.coli GroEL/GroES system 64,65. 
 
 
Fig. 2: In situ determined self-links contain structural information. (A) Full-length modelling of stress 70 
protein. Positioning two human Hsp70 domains structures (PDBs 4KBO/4N8E shown in cyan in upper structure) 
using Hsp70 structure in E. coli (PDB 2KHO shown in grey) as a template. The majority of conflict restraints are at 
the domain interface, which are indicated in the structure. Docking with the CLMS restraints resolved most of the 
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long-distance links at the interface and suggests alternative domain arrangement of Hsp70 (lower structure, shown 
in yellow). Histograms show the length distribution of all distance restraints on these protein structures before and 
after docking. (B) In situ flexibility within the mitochondrial chaperonin complex. The PDB structure 4PJ1 (shown in 
grey) portrays the heptameric 60 and 10 kDa heat shock protein complex. Identified crosslinks were matched to a 
single ring structure at the shortest distance between the crosslinked residues. (C) Assessment of human crosslinks 
in the context of an E. coli homologue. When mapping the human in situ CLMS distance restraints on GroEL (PDB 
4AAQ) half of the conflicting restraints were resolved.  
 
In situ protein-protein interactions revealed by CLMS 
In addition to self-links, we identified 152 PPI-links (protein-protein interaction links between 
two proteins, Tab. S2C). Our interaction network comprised 134 crosslinks between 
mitochondrial proteins (Fig. 3A). This included known interactors such as the respiratory chain 
complexes, ATP synthase, mitochondrial heat shock proteins and prohibitin – prohibitin 2 
interaction. We also identified 26 protein-protein interactions which are not yet annotated for 
human mitochondria in STRING or BioGrid databases (highlighted red in Fig. 3A). Some could 
be explained as possible substrates for mitochondrial heat shock proteins (see Hsp60 results 
described below). Others describe interactions between subunits of the respiratory chain 
complexes I, III, IV and V (ATP synthase) like the interaction between NADH dehydrogenase 
[ubiquinone] 1 alpha subcomplex subunit 5 and 7 (NDUA5 and NDUA7) which lacked an 
experimental evidence in humans so far but is known in putative homologs. Notably, multiple 
crosslinks (Tab. S2C) support the interaction between ATPase family AAA domain-containing 
protein 3A and 3B (ATD3A and ATD3B). Using loss- and gain-of-function approaches, Merle 
et al. 67 showed that the association of ATD3B with the ubiquitous ATD3A protein negatively 
regulates the interaction of ATD3A with matrix nucleoid complexes and contributes to 
mitochondrial homeostasis and metabolism specific in embryonic stem cells. We here found 
evidence for these heterodimers also in mature K-562 cells. 
We identified a much lower fraction of PPI-links (2.8% of all crosslinks, Fig. S5A), than 
the previous studies Schweppe et al. (29%) and Liu et al. (64%). As a plausible contributing 
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factor, we investigated different ways of FDR calculation employed by these studies. In 
contrast to Schweppe et al.22 and Liu et al.23, we separate PPI- and self-links for FDR analysis, 
due to a large prior probability that self-links are correct 37. If we do not separate these for FDR 
estimation, we see a substantial increase in PPI-links (on our tryptic subset, 16% up from 
3.3%, Fig. S5B). Unfortunately, many of these additional PPI-links are likely false, we gain 
53 PPI-links but also 22 PPI-link decoys, i.e. FDR 42%. Also, self-links decrease 3.4-fold, from 
2620 to 767. The need for separating PPI- and self-links for FDR analysis is further supported 
by all three studies seeing the majority of self-links supported by multiple peptide pairs 
(Fig. S5C). However, only after separate FDR estimation is this also the case for PPI-links 
(Fig. S5D). Taken together, this reveals a large dependency of PPI-links on the FDR method 
and suggests that the field needs to find a standardised and carefully tested agreement here.  
Nevertheless, different mitochondrial study approaches can corroborate each other by 
independently identifying novel interactions. We compared protein-protein interactions 
identified in our study to orthologous interactions found in murine mitochondria by Schweppe 
et al.22 and Liu et al.23. Here, 8 out of 14 protein-protein interactions are revealed by a single 
PPI-link (our least statistically confident protein-pairs) in our data were also found in mouse 
(Tab. S3). For example, ATP synthase subunits 𝛂 (ATPA) and d (ATP5H) were observed with 
multiple links in both mouse studies. Additionally, this approach also supported 6 (blue lines 
in Fig. 3A, Tab. S3) out of 26 protein-protein interactions that were not reported for human 
mitochondria in STRING or BioGrid (red lines in Fig. 3A).  
The presence of an Hsp60 structure allowed a closer look at the 17 PPI-links involving 
Hsp60 and other proteins. Importantly, 5 out of the 11 Hsp60 residues involved in these links 
located in the substrate channel at the inside of the Hsp60 ring structure, indicating that the 
proteins linked to those are likely substrates (Fig. 3B, Tab. S6). This includes a kinase, the 
mitochondrial glycerol kinase (GLPK) and a phosphatase, mitochondrial 
phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (PTPM1). Previous 
studies have shown that the E. coli GroEL/GroES system folds a wide spectrum of proteins 
19 
including certain kinases and phosphatases 68,69 but chaperonin substrates in the human 
system remain mostly unknown. 
 
 
Fig. 3: Protein-protein interaction analysis by CLMS. (A) Interaction network in human mitochondria. White 
circles represent proteins for which PPI-links were identified and lines illustrate these interactions. Thickness of 
lines scales with the number of PPI-links for each interaction. Lines are dashed when only one crosslink was 
detected. Lines are coloured according to interactions found in STRING or BioGrid database (black) or not (red). 
Additional blue lines indicate that this particular protein-protein interaction was also identified by Schweppe et al. 
and/or Liu et al. (Tab. S3). The most dense interaction network in human mitochondria was observed in the 
complexes of the oxidative phosphorylation, mitochondrial heat shock proteins and prohibitin. OMM: outer 
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mitochondrial membrane, IMS: intermembrane space, IMM: inner mitochondrial membrane. (B/C) Crosslinked 
amino acids in the 60 kDa heat shock protein complex, chain A. Residues being highlighted in green are located 
in the substrate channel, at the inside of the Hsp60 barrel. For example, Y223 crosslinks to GLPK and K387 
connects to PTPM1. Furthermore, crosslink sites localise to the interface of the two heptameric Hsp60 ring 
structures, including K87/89/551 (highlighted in green) and the K31/91 (highlighted in blue). These amino acids 
crosslink to MDHM or Hsp70 (see Tab. S6 for further information). Crosslinked residues at the outside of the barrel 
are coloured in pink. 
 
Conclusion 
In summary, these results support the use of CLMS as an in situ structural analysis method, 
to gain new insights into multimerisation and protein flexibility occurring in situ. Most of the 
proteome-wide CLMS studies to date focus on protein-protein interactions. We add a 
systematic view on clustered conflicts of long-distance crosslinks within proteins. We show 
that large-scale CLMS, even by using a standard non-cleavable crosslinker, generates 
sufficient data to start informing protein structure analysis across an entire cellular organelle. 
This workflow releases constraints for novel crosslinker designs and opens complex mixture 
CLMS to other crosslinker chemistries such as oxidative crosslinking or use of 
photoactivatable crosslinkers and amino acids. By further maturation of proteome-wide CLMS 
analysis, there will be more over-length conflicts which can be explained in a biological 
context. This will extend our structural knowledge in a unique way, being complementary to 
traditional structure elucidation methods.  
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